ARCHIVES

New Drug for Lymphoma Enters Phase II Trial

This article is from The Cancer Letter archive.

Vol. 27 No. 5 | May 28, 2004

Download PDF Visit The Full Archive

Related Articles

In Brief: Columiba Adds Presbyterian to Center’s Name: Clinton’s Mother Honored; DeVita move Rumored

March 5, 1993

DCT Board Insists On Being Heard In Development Of CCOP Guidelines

February 19, 1982

Gleevec Produces 59% Response Rate In Gastrointestinal Stromal Tumors

May 25, 2001

NIH Bias Against Young Investigators Threatens To “Deprime The Pump,” Zerhouni Says.

February 15, 2008

Cancer Planners Revise Some Project Areas, Drop Some, Add New Ones

February 8, 1974

Genentech Says Phase III Trial Shows Avastin Improved PFS For Ovarian Cancer

March 26, 2010